已收盤 11-06 16:00:00 美东时间
+0.910
+14.80%
11月7日,LightPath Technologies(LPTH)收涨14.8%,报7.06美元,成交额2001.99万美元,市值4.94亿美元。 行情数据...
11-07 07:03
11月3日,LightPath Technologies(LPTH)收跌5.8%,报7.63美元,成交额2191.85万美元,市值5.34亿美元。 行情数据 ...
11-03 07:02
今日重点评级关注:摩根士丹利:维持西部数据"超配"评级,目标价从643美元升至668美元;摩根大通:维持西部数据"超配"评级,目标价从600美元升至650美元
10-26 12:30
10月24日,LightPath Technologies(LPTH)收涨3.85%,报7.29美元,成交额2076.77万美元,市值5.11亿美元。 行情数据...
10-24 06:08
Piper Sandler analyst Clarke Jeffries maintains LightPath Technologies (NASDAQ:LPTH) with a Overweight and lowers the price target from $15 to $13.
10-24 00:40
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 06:06
Order brings total awards from the customer to more than $19 million since July 1 - double the customer's total for all of fiscal 2026 - supporting counter-UAS systems, one of the fastest-growing areas of defense demand ORLANDO, FL / ACCESS Newswire / October 13, 2026 / LightPath Technologies, Inc. ...
10-13 20:54
LightPath Technologies shares are trading higher after the company announced it has been awarded a funded prototype agreement under the Critical Low-risk Electro-optic Alternatives for Resilience program.
09-18 01:54
LightPath Technologies (NASDAQ:LPTH) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.02) by 200 percent. This is a 62.5 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $21.162 ...
09-11 04:06
今日重点评级关注:BTIG:维持Kazia Therapeutics"买入"评级,目标价从34美元升至40美元;摩根大通:维持Annexon"超配"评级,目标价从10美元升至14美元
09-02 14:07